Modern Fertility→Ro
Acquisition · Cash · announced May 19, 2021
Announced
May 19, 2021
Closed
Jul 15, 2021
Economics
Cash()
Pre-deal · pre-deal mark: 2020, year precision · TechCrunch — Series B funding coverage, 2020
Estimated acquisition price ~$150-225M (not officially disclosed)
Target
Modern Fertility
Fertility · Care delivery
HQ San Francisco, CA · Founded 2017
At-home fertility testing and telehealth
- Crunchbase - crunchbase.com/organization/modern-fertility
- TechCrunch - acquisition coverage (May 2021)
- Company website - modernfertility.com
Acquirer
Ro
Digital Health
HQ New York, NY
Why this buyer
Curated copy from the verified dataset — not an 8-K LLM summary
Added at-home fertility testing to Ro's telehealth platform, expanding women's health services
Evidence ladder
Secondary (press / IR)
Press reports (Fierce Healthcare, May 2021)
Limitations
- Single-source or weak corroboration — treat valuation and timing as directional.
- Estimated acquisition price ~$150-225M (not officially disclosed)
- Pre-deal valuation sourced from: TechCrunch — Series B funding coverage, 2020. Pre-deal market-cap and funding citations do not corroborate the acquisition.
Valuation peers · Fertility
Same sector, same deal type, announced within ±3 years, disclosed value within 0.25×–4× of this transaction. Ranked by evidence class, then same acquirer.
| Target | Acquirer | Announced | Value | Why included |
|---|---|---|---|---|
| Eugin Group (North American operations) | KKR (via IVI-RMA) | Nov 1, 2023 | value band | |
| Indira IVF | BPEA EQT | Jul 28, 2023 | value band | |
| Hamilton Thorne | Astorg | Jul 22, 2024 | value band |
Same-sector adjacency — not valuation peers
These deals share the sector tag and window but sit outside the 0.25×–4× value band. The dataset keeps them for clinical adjacency, not as price comps.
| Target | Acquirer | Announced | Value | Vs this deal |
|---|---|---|---|---|
| IVI-RMA Global | KKR | Mar 1, 2022 |
Other verified deals by Ro
Acquirer program history not already listed as a valuation peer or adjacency row.
| Target | Acquirer | Announced | Value | Sector |
|---|---|---|---|---|
| Nurx | Ro | Dec 15, 2021 | General Wellness |
Patient empowerment context
Patient empowerment baseline (HLTH 2022)
No curated mapping — Modern Fertility (Fertility). HLTH/Outcomes4Me 2022 baseline is Breast cancer care continuum (HLTH 2022). No curated mapping for this target in the verified crosswalk.
Research workspace (includes heuristic crosswalk) →Related verified workspaces
Lacuna is a curated public-source sample, not a census of women's-health M&A. Coverage varies by sector, geography, disclosure availability, and women's-health scope. Undisclosed transaction values are excluded from disclosed-value totals.
Curated verified dataset v9 · updated 2026-09-20 · 1 citations on this deal · Data compiled from public sources for educational visualization. Verify independently before any commercial use.